Recombinant deoxyribonucleoside kinase from Drosophila melanogaster can improve gemcitabine based combined gene/chemotherapy for targeting cancer cells. (2019). Biomolecules and Biomedicine, 19(4), 342-349. https://doi.org/10.17305/bjbms.2019.4136